A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies
|
|
|
- Oswald Armstrong
- 5 years ago
- Views:
Transcription
1 A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies Lynda Mackin, PhD, AGPCNP-BC, CNS University of California San Francisco School of Nursing 1
2 Alzheimer s Association 2
3 Alzheimer s Association 3
4 The Brain 4
5 DSM-5:Dx Initial Steps: Mild NCD: Step 1 A. Evidence of cognitive decline from previous higher level of functioning in 1 or more cognitive domains. Due to concern of individual, reliable historian or practitioner and preferably documented modest impairment on standardized neuropsychological testing B. No IADLs deficits, but may require compensation C. Rule out delirium D. Deficits not caused by other mental disorders such as MDD or schizophrenia APA
6 DSM-5:Dx Initial Steps: Mild NCD: Steps 2 & 3 Step 2: Specify subtype Step 3: Specify with our without behavioral disturbances APA
7 DSM-5:Dx Initial Steps: Mild versus Major NCD Major NCD: A. Evidence of cognitive decline from previous higher level of functioning in 1 or more cognitive domains. Due to concern of individual, reliable historian, or practitioner and preferably documented substantial impairment on standardized neuropsychological testing. B. Interferes with daily IADLs C. Rule out delirium D. Deficits not caused by other mental disorders, such as MDD or schizophrenia APA
8 DSM-5:Dx Initial Steps: Mild versus Major NCD Step 2: Specify Subtype Step 3: Specify with or without behavioral disturbances Step 4: Specify severity: A. Mild: Difficulty with IADLs B. Moderate: Difficulty with ADLs C. Severe: Complete dependence APA
9 Common Subtypes of NCD Alzheimer s Disease (AD): Most common form, at least 50% of cases Vascular dementia: Multi-infarct, Diffuse White Matter (Binswanger) Common in elderly, esp. w/ vascular dz risk factors Alcoholism Drugs/medication intoxication Parkinson s Disease (PD) 9
10 Less common causes of Vitamin Def: B1; B12; Nicotinic Acid Endocrine d/o, organ failure: Hypothyroid; adrenal dysfunction; hyper- or hypo- parathyroidism; liver failure; respiratory failure Chronic infections: HIV; neurosyphilis; papovavirus; TB, fungal; protozoal; Whipple s dz NCD Head trauma/brain damage: dementia pugilistica; chronic SDH; postanoxia; postencephalitis; NPH Toxic d/o: Drugs; opioid poisoning; heavy metal intox; dialysis; organic toxins Psychiatric illnesses: Depression; schizophrenia; conversion reaction Harrison's online: aspx?aid=
11 Less common causes of Degenerative d/o: Huntington's Dz Dementia with Lewy Bodies; (DLB) Progressive Supranuclear Palsy Multisystem Atrophy Hereditary ataxias Motor neuron dz (ALS) Frontotemporal Dementia (FTD- most common under age 65); NCD Corticobasal degeneration; MS Adult Down s Syndrome with AD ALS Parkinson s Complex Dementia of Guam; Prion Dz (Creutzfeldt-Jacob) Harrison's online:
12 Less common causes of NCD Others: Sarcoidosis Vasculitis CADASIL Acute intermittent porphyria Recurrent non convulsive seizures Neoplastic: Primary or metastatic brain tumor Paraneoplastic limbic encephalitis 12
13 Medical w/u for NCD Usual: History, PE, detailed neuro exam, depression screening Labs: TSH, B12, CBC, Lytes, CT/MRI Optional/Focused Psychometric testing CXR Lumbar puncture LFTs Renal Fx Urine toxin screen HIV Apolipoprotein E (APOE) RPR or VDRL 13
14 Key functional areas of the brain 14
15 Clinical Presentation Alzheimer s Disease (AD) 1 st Sx: Memory Loss Mental Status: Episodic memory loss Neuropsych: Initially normal Neuro Exam: Initially normal Imaging: Entorhinal cortex and hippocampus atrophy Frontal Temporal Dementia (FTD) 1 st Sx: Apathy; poor judgment/insight; speech/language impairment; hyperorality MS: Frontal/executive, language, spares memory NP: Apathy, disinhibition, hyperorality, euphoria, depression Exam: Vertical gaze palsy, axial rigidity, dystonia, alien hand or MND Imaging: Frontal, insular +/- temporal atrophy; spares posterior parietal lobe 15
16 Caserta, M., Caccioppo, D., Lapin, G., Ragin, A., Groothuis, D. (1998). Blood Brain Barrier Integrity in Alzheimer's Disease Patients and Elderly Control Subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 10:
17 Clinical Presentation Dementia-Lewy Body (DLB) or NCDLB 1 st Sx: Visual hallucinations, REM sleep d/o, delirium, Capgras syndrome, parkinsonism Mental Status: Drawing & frontal/executive impaired; spares memory, delirium prone Neuropsych: Visual hallucinations, depression, sleep problems, delusions Neuro Exam: Parkinsonism Imaging: Posterior parietal atrophy; hippocampi larger c/t AD Vascular Dementia 1 st Sx: May be sudden; apathy; falls; focal weakness MS: Frontal/executive; cognitive slowing; can spare memory NP: Apathy, delusions, anxiety Exam: Motor slowing, spasticity, can be normal Imaging: Cortical +/- subcortical infarcts; confluent white matter disease 17
18 Brain MRI, T2 sequence: multiple cortical and subcortical infracts in a vascular dementia patient. Tsiptsios et al. (2003). Annals of General Hospital Psychiatry.2:8 doi: /
19 Screening Tests Mini Cog: /fpinfo/docs/minicogassessmentform.pdf MMSE-2: SLUMS: St Louis Univ. Mental Status veys/slumsexam_05.pdf MoCA: Montreal Cognitive Assessment: 19
20 Medicare Annual Wellness Visit (AWV) Cognitive assessment is a required element No specific cognitive screen tool is required 20
21 Mini Cog 21
22 MMSE-2 22
23 SLUMS: St. Louis University Mental Status Examination 23
24 MoCA: Montreal Cognitive Assessment Version 2 24
25 Informant Assessment Interview/ history from reliable informant Tools available: General Practice Cog: GPCOG Assessment Test Has patient and informant components Short Form Informant Questionnaire on Cognitive Decline in the Elderly: Short IQCODE AD8: Dementia Screening Interview 25
26 0-1: Normal > 2: Cognitive impairment is likely to be present 26
27 Alzheimer's Disease Classification (2011) Prior criteria from 1984 Reflects Spectrum of dz Advances in understanding of dz 3 stages Early Middle Final: sx of dementia are present Preclinical: Before sx occur Pathology in brain present MCI: Memory and/or thinking problems Dementia: Impairs function 27
28 Mild Cognitive Impairment (MCI) Key differential: no impact on function Normal aging results in slowing of processing and decreased ability to learn new information If the cognitive impairment does negatively impact function, then impairment is beyond MCI Two types: Amnestic: memory impairment Nonamnestic: decisions, sequence, time and steps 28
29 National Institute on Aging: MCI Concern about a change in cognition relative to previous functioning Impairment of one or more cognitive functions, like memory and problem solving, that is greater than expected for the person s age and education. Memory is the function most commonly impaired among people who progress from MCI to Alzheimer s dementia. Preserved ability to function independently in daily life, though some complex tasks may be more difficult than before No dementia 29
30 Concern regarding change in cognition Impairment in 1 or more cognitive domains Memory Executive function Attention Language Core Clinical Criteria Visuospatial Preservation of functional independence Not demented for dx of MCI 30
31 MCI A syndrome: clinical, cognitive and functional criteria Prevalence: 10-20% of age 65 Episodic memory impairment (amnestic) that represents the pre clinical stage of AD: MCI associated with AD In establishing presence of MCI: Longitudinal data is most helpful Look for medical problems that may be cause Look for genetic causes Biomarkers will help clarify this condition 31
32 Cognitive impairment diagnostic algorithm Hazzard s Geriatric Medicine and Gerontology, on-line version. Figure
33 33
34 Thank you for your attention. 34
35 Depth%20Reports/10/ cfm 35
WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
Non Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
Form D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)
Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following
DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step?
Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University of California San Francisco
Dementia and Alzheimer s disease
Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
A Neurologist s Approach to Altered Mental Status
A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Department of Neurology University of California San Francisco October 23, 2008 The speaker has no disclosures Case 1 A 71 year-old
DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)
SUPPLEMENT 2 RELEVANT EXTRACTS FROM DSM-5 The following summarizes the neurocognitive disorders in DSM-5. For the complete DSM-5 see Diagnostic and Statistical Manualof Mental Disorders, 5th edn. 2013,
What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias
What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias Presenter: Kim Bailey, MS Gerontology, Program & Education Specialist, Alzheimer s Orange County 1 1 Facts About Our
Assessing and Managing the Patient with Cognitive Decline
Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor
Mild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
Diagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
Cognitive Evaluation in Primary Care. Scott T. Larson, MD Clinical Assistant Professor University of Iowa
Cognitive Evaluation in Primary Care Scott T. Larson, MD Clinical Assistant Professor University of Iowa scott-larson@uiowa.edu Objectives Understand the subtypes of dementia, and the DSM-5 categorization
Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
Delirium & Dementia. Nicholas J. Silvestri, MD
Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts
Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit
Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features
Cognitive Assessment 4/29/2015. Learning Objectives To be able to:
Supporting the Desire to Age in Place: Important Considerations for the Aging Population AGENDA 8:45 9:00 AM Geriatric Principles Robert L. Kane, MD *9:00 9:55 AM Cognitive Assessments Ed Ratner, MD 10:00
Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries
Clinical Differences Among Four Common Dementia Syndromes a program of Morningside Ministries Introduction Four clinical dementia syndromes account for 90% of all cases after excluding reversible causes
Dementia and Delirium:
Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive
DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER
OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for
ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health
ALZHEIMER S DISEASE OVERVIEW Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health Prevalence AD: DEMOGRAPHY AND CLINICAL FEATURES Risk and protective factors Clinical features and
NACC Minimum Data Set (MDS) Public Data Element Dictionary
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
DEMENTIA ANDREA BERG, MD
DEMENTIA ANDREA BERG, MD What Is Dementia? Decline in memory, language, problem-solving and other cognitive skills that affects a persons ability to perform everyday activities Progressive and disabling
Alzheimer s disease dementia: a neuropsychological approach
Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital
Form A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
The ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
Introduction to Dementia: Diagnosis & Evaluation. Created in March 2005 Duration: about 15 minutes
Introduction to Dementia: Diagnosis & Evaluation Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:
Differentiating Dementia Diagnoses
Differentiating Dementia Diagnoses Waitemata PHO 21 October 2014 Dr Michal Boyd, RN, NP, ND Nurse Practitioner Older Adults School of Nursing & Freemasons Dept. of Geriatric Medicine The University of
Diagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology
Diagnosis and management of non-alzheimer dementias Melissa Yu, M.D. Department of Neurology AGENDA Introduction When to think of alternate diagnoses Other forms of dementia Other reasons for confusion
What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia
What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:
Cognitive disorders. Dr S. Mashaphu Department of Psychiatry
Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during
Approach to Cognitive Disorders in Primary Care
Approach to Cognitive Disorders in Primary Care What can reasonably be done in an office visit? What about screening for cognitive disorders? USPSTF (2014) doesn t recommend screening: magnitude of clinically
GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017
Dementia: It s Not Always Alzheimer s
Dementia: It s Not Always Alzheimer s A Caregiver s Perspective Diane E. Vance, Ph.D. Mid-America Institute on Aging and Wellness 2017 My Background Caregiver for my husband who had Lewy Body Dementia
NEUROPSYCHOMETRIC TESTS
NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract
Differential Diagnosis
Differential Diagnosis 2 2.1 Introduction AD accounts for up to 75 % of all dementia cases. The differential diagnosis with other conditions is sometimes challenging since several disorders may produce
Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.
Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence
Mining for Lost Memories: A Best Practice Approach for Alzheimer s Disease Diagnosis
Mining for Lost Memories: A Best Practice Approach for Alzheimer s Disease Diagnosis Michael Rosenbloom, MD and Terry Barclay, PhD HealthPartners Center for Dementia and Alzheimer s Care Presentation Outline
OLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.
Psychiatric disorders of the elderly OLD AGE PSYCHIATRY Dementia Depression Delusional disorder/late onset schizophrenia Delirium Dementia definition LOCALISATION OF CEREBRAL FUNCTION Impairment of multiple
DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease
What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There
Caring Sheet #11: Alzheimer s Disease:
CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses
Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network
Neuroimaging for dementia diagnosis Guidance from the London Dementia Clinical Network Authors Dr Stephen Orleans-Foli Consultant Psychiatrist, West London Mental Health NHS Trust Dr Jeremy Isaacs Consultant
Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136
A Abbreviated mental test (AMT) diagnostic performance, GPCOG, 205 screening instrument, 81 timescales, 214 ACE and revision (ACE-R). See also Addenbrooke s cognitive examination (ACE) clinical diagnosis,
Dementia A syndrome, not a disease. Mordechai Lavi, MD Geriatric Physician
Dementia A syndrome, not a disease Mordechai Lavi, MD Geriatric Physician Objectives 1. To improve our understanding of how we diagnose a dementia syndrome 2. Understand the workup that should be expected
Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician
Dementia Aetiology, pathophysiology and the role of neuropsychological testing Dr Sheng Ling Low Geriatrician Topics to cover Why is dementia important What is dementia Differentiate between dementia,
DIFFERENTIAL DIAGNOSIS OF NEUROCOGNITIVE DISORDERS
DIFFERENTIAL DIAGNOSIS OF NEUROCOGNITIVE DISORDERS Maria D. Llorente MD Associate Chief of Staff, Mental Health Washington DC VA Medical Center Professor of Psychiatry, Georgetown University School of
I do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
MOVEMENT DISORDERS AND DEMENTIA
MOVEMENT DISORDERS AND DEMENTIA FOCUS ON DEMENTIA WITH LEWY BODIES MADHAVI THOMAS MD NORTH TEXAS MOVEMENT DISORDERS INSTITUTE, INC DEMENTIA de men tia dəˈmen(t)sh(ē)ə/ nounmedicine noun: dementia a chronic
The Ethics of Working with Aging Donors
The Ethics of Working with Aging Donors Tuesday, May 2, 2017 3:30pm Speakers Marla Beck Owner, Andelcare James R. Carney, CFP Morgan Stanley, Financial Advisor Janell Johnson Associate Director of Development:
Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota
Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function
SHARED CARE OF MCI/EARLY DEMENTIA
SHARED CARE OF MCI/EARLY DEMENTIA BY DR. OLUFEMI BANJO MD, DTM, DCP, DIPA&DS, DHM, M.Med.Sc, FRCP(C) GERIATRIC PSYCHIATRIST. ASSISTANT MEDICAL DIRECTOR, ADULT MENTAL HEALTH AND ADDICTION, GRAND RIVER HOSPITAL
FTD basics! Etienne de Villers-Sidani, MD!
FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant
Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
Is PET/CT really helpful in diagnosing Alzheimer s Disease?
Is PET/CT really helpful in diagnosing Alzheimer s Disease? J. Rudolf MD Ph.D. Consultant in Neurology, Dept. of Neurology, General Hospital Papageorgiou Thessaloniki, Greece Conflict of Interest PET/CT
P20.2. Characteristics of different types of dementia and challenges for the clinician
P20.2. Characteristics of different types of dementia and challenges for the clinician, professor Danish Dementia Research Center Rigshospitalet, University of Copenhagen (Denmark) This project has received
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology
Dementia Amber Eker, MD Assistant Professor Near East University Department of Neurology Dementia An acquired syndrome consisting of a decline in memory and other cognitive functions Impairment in social
UDS version 3 Summary of major changes to UDS form packets
UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options
3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES
DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING MILTA LITTLE, DO, CMD DUKE UNIVERSITY SCHOOL OF MEDICINE FINANCIAL DISCLOSURES Dr. Little has no relevant financial disclosures to report Dr. Little will
Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1
Delirium, Dementia, and Amnestic Disorders Dr.Al-Azzam 1 Introduction Disorders in which a clinically significant deficit in cognition or memory exists The number of people with these disorders is growing
AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services
AGED SPECIFIC ASSESSMENT TOOLS Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services Issues in assessing the Elderly Association between biological, psychological, social and cultural
Common Forms of Dementia Handout Package
Common Forms of Dementia Handout Package Common Forms of Dementia 1 Learning Objectives As a result of working through this module, you should be better able to: 1. Describe clinical features of 4 major
Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia
86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile
Parkinsonian Disorders with Dementia
Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University
Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues
Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic s? The Debate Continues Ever since new criteria came out for a research diagnosis of prodromal/preclinical
The Person: Dementia Basics
The Person: Dementia Basics Objectives 1. Discuss how expected age related changes in the brain might affect an individual's cognition and functioning 2. Discuss how changes in the brain due to Alzheimer
As a general cognitive screening tool or as part of an annual exam (Medicare Annual Wellness Visit).
EMR DECISION SUPPORT TOOLS FOR ALZHEIMER S AND RELATED DEMENTIAS 1. Screening Tool Criteria For When to Use: As a general cognitive screening tool or as part of an annual exam (Medicare Annual Wellness
Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for Clinical Practice. Hypothesized Key Players in the Pathogenesis of AD
AD is a Neurodegenerative Disease as Seen in the PET Scan and is Characterized by Amyloid Plaques and Neurofibrillary Tangles Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for
PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW
TMH Professionals, LLC, American College of Psychotherapy & LPCA present PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW Module 7: Differential Diagnosis, Scope of Practice,
Dementia. Assessing Brain Damage. Mental Status Examination
Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological
Significance A Busy Clinician's Guide to Seniors with Memory Loss
Significance A Busy Clinician's Guide to Seniors with Memory Loss Victoria Braund MD FACP CMD Division of Geriatrics. NorthShore University HealthSystem Alzheimer's disease is the sixth leading cause of
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,
ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey
ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy
Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends
ASSESSING COMPETENCE Michael A Hill MD UNC Psychiatry 2008 Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives,
Dementia With A Twist
Dementia With A Twist Christina Tieu Geriatric Update for the Primary Care Provider November 17 th, 2016 2016 MFMER slide-1 79 y/o woman originally from Greece CC: paranoia, abulia and mutism Accompanied
Imaging of Alzheimer s Disease: State of the Art
July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression
Dementia and Healthy Ageing : is the pathology any different?
Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association
Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee
Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is
The Basics of Alzheimer s Disease
2017 Memory Loss Conference The Basics of Alzheimer s Disease Tom Ala, MD Center for Alzheimer s Disease and Related Disorders Southern Illinois University School of Medicine Springfield, Illinois SIU
Dementia Diagnosis Guidelines Primary Care
Dementia Diagnosis Guidelines Primary Care Dementia Diagnosis Primary Care Guidelines Introduction Dementia is a long term condition, which primarily affects people over the age of 65 (late on-set dementia)
DEMENTIA (Major Neurocognitive Disorder) SUSAN BEHNAWA, M.D. DIVISION OF GERIATRIC MEDICINE AND GERONTOLOGY UC IRVINE HEALTH SCHOOL OF MEDICINE
DEMENTIA (Major Neurocognitive Disorder) SUSAN BEHNAWA, M.D. DIVISION OF GERIATRIC MEDICINE AND GERONTOLOGY UC IRVINE HEALTH SCHOOL OF MEDICINE Objectives Review the epidemiology and social impact of Dementia
Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss
Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss Incidence of Common Neurological Diseases Incidence New Cases Disease (per 100,000) (per
Vascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center
Vascular Dementia Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center none Disclosures Objectives To review the definition of Vascular Cognitive Impairment (VCI);
Dementia: general overview
132 CHAPTER 5 Organic illness Dementia: general overview Essence Dementia is a syndrome characterized by progressive, usually irreversible, global cognitive deficits. Often memory impairment is the first
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre
Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5
Prof Tim Anderson. Neurologist University of Otago Christchurch
Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral
Henry Brodaty. Depression, Dementia, Pseudodementia, Pseudodepression.
Henry Brodaty Depression, Dementia, Pseudodementia, Pseudodepression. Centre for Healthy Brain Ageing www.cheba.unsw.edu.au University of New South Wales (UNSW Australia) Depression, apathy & cognition
Dementia: Diagnosis and Treatment
Dementia: Diagnosis and Treatment Outline 1. Risk factors and definition of dementia 2. Types of Dementias 3. MMSE and testing 4. Treatment options Cognitive decline with aging Mild changes in memory and
Neurologic Examination
John W. Engstrom, MD October 16, 2015 Neurologic Examination Overview The Neurologic Examination Neurologic Examination John W. Engstrom, M.D. Dept. of Neurology University of California, San Francisco
Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana
Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana FINANCIAL DISCLOSURE No potential conflict of interest to disclose. OBJECTIVES
Dr Roger Cable NHS Dumfries and Galloway
Dr Roger Cable NHS Dumfries and Galloway Young Onset Dementia Statistics What is dementia Diagnosing dementia History Examination Tests Subtypes of dementia 315000 Cost of dementia (Alzheimer s society)
Diagnosis of Dementia: Clinical aspects
Diagnosis of Dementia: Clinical aspects George Tadros Consultant in Old Age Psychiatry Professor of Old Age Liaison Psychiatry, Warwick Medical School, University of Warwick Visiting Professor of Mental
Assessment Toolkits for Lewy Body Dementia
Study : Assessment Toolkits for Lewy Body Dementia There are two toolkits, depending on whether the patient is presenting with a primary cognitive problem or with cognitive decline in the context of established
Moving Targets: An Update on Diagnosing Dementia in the Clinic
Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures